[Federal Register Volume 62, Number 89 (Thursday, May 8, 1997)]
[Notices]
[Page 25210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-11923]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 31, 1996, and published in the Federal 
Register on January 9, 1997 (62 FR 1342), MD Pharmaceutical, Inc., 3501 
West Garry Avenue, Santa Ana, California 92704, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Methylphenidate (1724)......................  II                        
Diphenoxylate (9170)........................  II                        
------------------------------------------------------------------------

    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of MD Pharmaceutical, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. Therefore, pursuant to 21 U.S.C. Sec. 823 
and 28 CFR 0.100 and 0.104, the Acting Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacturer of 
the basic classes of controlled substances listed above is granted.

    Dated: April 24, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. 97-11923 Filed 5-7-97; 8:45 am]
BILLING CODE 4410-09-M